Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,777 results for "Product Liability Law & Strategy"...

Navigating the Potentially Conflicting Demands of U.S. Discovery Obligations and EU Data Protection Laws
July 28, 2011
Complying with U.S. discovery demands can involve enormous effort and expense, even in the best of circumstances. But the process can become even more difficult when EU data protection laws prohibit the disclosure of the requested information.
The SEC's Renewed Focus on Regulation FD
July 28, 2011
In the past 18 months, the SEC has brought two Regulation Fair Disclosure ("Regulation FD") enforcement actions. While this number may not appear particularly significant, past history (the SEC brought seven enforcement actions from 2002 to 2005) and recent SEC guidance indicates that the SEC has renewed its emphasis on enforcing Regulation FD.
Drug & Device News
July 27, 2011
Recent developments are highlighted.
News Briefs
July 27, 2011
Highlights of the latest franchising news from around the country.
Judge Rules GSK's 'Nerve Center' in Philadelphia for Paxil Suits
July 26, 2011
Lawyers for GlaxoSmithKline (GSK) were enjoying something of a winning streak in their efforts to remove drug product liability lawsuits to federal court ' and keep them there ' by arguing that it has converted to a limited liability company that is based in Delaware. But that streak may now be over.
Litigation Upfdate
July 26, 2011
An in-depth review of recent litigation that affects this practice area.
Practice Tip: Pleading Medical Device Complaints
July 26, 2011
The heightened pleading requirements of <i>Bell Atlantic Corp. v. Twombly</i> require that practitioners who plan to file a complaint in a medical device case be even more cautious than usual. Otherwise, they may be subject to a dismissal on the pleadings.
Effective Use of Evidence-Based Medicine to Challenge Causation Testimony
July 26, 2011
Medical experts testifying about causation in toxic tort, medical device, and pharmaceutical litigation frequently claim to base opinions upon a dispassionate review of the scientific literature, the same analysis they perform in their clinical practices. But peeling back the fa'ade often reveals that they have done nothing of the kind.
Economic Analysis in ERISA Litigation over Fiduciary Duties
July 25, 2011
Continuation of the in-depth discussion begun last month, with emphasis on Implications of behavioral finance for ERISA litigation.
Retail Tenants Need to ZIP Up Their Class-Action Defenses in CA
July 25, 2011
Retail tenants in California ' and perhaps those in other states as well ' that collect ZIP Codes may very well find themselves the subject of putative class actions, the penalties for which could be substantial.

MOST POPULAR STORIES